CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of EUR 73.73 billion. The enterprise value is 135.55 billion.
Market Cap | 73.73B |
Enterprise Value | 135.55B |
Important Dates
The last earnings date was Thursday, May 1, 2025.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | Apr 22, 2025 |
Share Statistics
Current Share Class | 1.27B |
Shares Outstanding | n/a |
Shares Change (YoY) | -1.77% |
Shares Change (QoQ) | +0.24% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.26B |
Valuation Ratios
The trailing PE ratio is 15.09 and the forward PE ratio is 10.35.
PE Ratio | 15.09 |
Forward PE | 10.35 |
PS Ratio | 0.21 |
PB Ratio | 1.03 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.89, with an EV/FCF ratio of 24.66.
EV / Earnings | 27.75 |
EV / Sales | 0.40 |
EV / EBITDA | 8.89 |
EV / EBIT | 16.15 |
EV / FCF | 24.66 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.05.
Current Ratio | 0.82 |
Quick Ratio | 0.59 |
Debt / Equity | 1.05 |
Debt / EBITDA | 4.79 |
Debt / FCF | 13.67 |
Interest Coverage | 3.08 |
Financial Efficiency
Return on equity (ROE) is 6.93% and return on invested capital (ROIC) is 3.71%.
Return on Equity (ROE) | 6.93% |
Return on Assets (ROA) | 2.31% |
Return on Invested Capital (ROIC) | 3.71% |
Return on Capital Employed (ROCE) | 5.60% |
Revenue Per Employee | 1.34M |
Profits Per Employee | 18,825 |
Employee Count | 300,000 |
Asset Turnover | 1.49 |
Inventory Turnover | 19.31 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.63% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +10.63% |
50-Day Moving Average | 60.59 |
200-Day Moving Average | 55.03 |
Relative Strength Index (RSI) | 44.12 |
Average Volume (20 Days) | 622 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.58 |
Income Statement
In the last 12 months, CVS Health had revenue of EUR 348.56 billion and earned 4.89 billion in profits. Earnings per share was 3.88.
Revenue | 348.56B |
Gross Profit | 47.20B |
Operating Income | 8.64B |
Pretax Income | 6.65B |
Net Income | 4.89B |
EBITDA | 12.90B |
EBIT | 8.64B |
Earnings Per Share (EPS) | 3.88 |
Balance Sheet
The company has 11.71 billion in cash and 75.14 billion in debt, giving a net cash position of -63.43 billion.
Cash & Cash Equivalents | 11.71B |
Total Debt | 75.14B |
Net Cash | -63.43B |
Net Cash Per Share | n/a |
Equity (Book Value) | 71.34B |
Book Value Per Share | 56.40 |
Working Capital | -14.59B |
Cash Flow
In the last 12 months, operating cash flow was 8.10 billion and capital expenditures -2.61 billion, giving a free cash flow of 5.50 billion.
Operating Cash Flow | 8.10B |
Capital Expenditures | -2.61B |
Free Cash Flow | 5.50B |
FCF Per Share | n/a |
Margins
Gross margin is 13.54%, with operating and profit margins of 2.48% and 1.40%.
Gross Margin | 13.54% |
Operating Margin | 2.48% |
Pretax Margin | 1.91% |
Profit Margin | 1.40% |
EBITDA Margin | 3.70% |
EBIT Margin | 2.48% |
FCF Margin | 1.58% |
Dividends & Yields
This stock pays an annual dividend of 2.44, which amounts to a dividend yield of 4.22%.
Dividend Per Share | 2.44 |
Dividend Yield | 4.22% |
Dividend Growth (YoY) | 3.83% |
Years of Dividend Growth | 3 |
Payout Ratio | 63.88% |
Buyback Yield | 1.77% |
Shareholder Yield | 5.99% |
Earnings Yield | 6.63% |
FCF Yield | 7.46% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CVS Health has an Altman Z-Score of 2.12. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.12 |
Piotroski F-Score | n/a |